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Abstract. The interaction of CT DNA by two anionic Ru(III) complexes with N-substituted salicylide-
nimine ligands was investigated by spectroscopic titration and cyclic voltammetry. The result gives a  
surprising evidence for intercalation of DNA by the negatively charged complex species containing non 
typical intercalating ligands with Kb of order 104 M−1. Na[RuCl2(N-R-5-X-salim)2], where R represents 
butyl or phenyl and X = H, Cl, were characterized on the basis of elemental analysis, MALDI-TOF mass  
spectrometry, infrared, UV / visible spectroscopic measurements and cyclic voltammetry. (doi: 
10.5562/cca2216)  
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INTRODUCTION 
Ruthenium compounds have been the subject of great 
interest and impressive development in last decades for 
many reasons, especially due to their catalytic1−4 and 
anticancer activities.5−11 Ruthenium generally demon-
strates affinity toward N-donor molecules such as  
proteins and DNA. The mechanism of the action of 
antitumor-active ruthenium compounds is not entirely 
known. Closely, it is thought that the complexes  
containing chlorides, or other easily leaving groups,  
can hydrolyze in vivo, allowing the covalent binding  
of the nucleobases from DNA to ruthenium.12 Many 
Ru(II) and Ru(III) compounds with numerous different 
ligands are reasonably synthesized and investigated for 
the purpose of possible application in medicine and 
catalysis. There are no many complexes containing 
Schiff bases derived from salicyladehyde described  
in literature, although such ligands generally show  
considerable stereochemical flexibility and capability to 
tune the reduction potential of metal center, acting as  
N- or N,O ligands.13,14 Some of them are described as 
very good catalysts in organic synthesis because the 
presence of salicylaldimine in the molecule increases 
the stability and catalytic activity.15 Such ligands are 
derived from 2,4,6-tris substituted phenylamines and 
salicylaldehyde containing attached quaternary ammo-
nium group to increase hydrophilic character.16−18  
Furthermore, some ruthenium complexes with 
salicyladi-mines showed significant biological activity 
against some bacteria, in contrast to the less active free  
ligands.19 In addition, two dichloro-bis[N-phenyl-5-
substituted-salicylideniminato-N,O]ruthenate(III) are 
described as electrochemical mediators for the low 
potential amperometric determination of ascorbic  
acid.20,21 
We aimed to investigate interaction of Ru(III) 
complexes containing simple Schiff bases derived from 
salicylaldehyde with DNA and we report spectroscopic 
and electrochemical evidence of CT DNA intercalation 
by two dichloro-bis[N-substituted-5-X-salicylideni-
minato-N,O]ruthenate(III) compounds, hereinafter 
Na[RuCl2(N-R-5-X-salim)2] where R represents butyl or 
phenyl, while X = H, Cl.  
 
EXPERIMENTAL 
Chemicals were purchased from commercial  
sources and used without further purification. Calf  
thymus DNA (CT DNA) was purchased from Sigma 
Aldrich. 
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Synthesis  
Preparation of Ligands 
N-substituted-5-X-salicylidenimines, hereinafter N-R-5-
XsalimH (R = C4H9, C6H5, X = H, Cl) were prepared by 
simple condensation of butyl amine with salicylalde-
hyde and aniline with 5-chlorosalicylalde-hyde in molar 
ratio 1 : 1 at room temperature. Solid N-phenyl-5-chlo-
rosalicylidenimine was recrystallized from ethanol at  
70 °C with 70−80 % yield. 
 




N,O]ruthenate (III), hereinafter Na[RuCl2(N-Ph-5-Cl-
salim)2], was prepared according to the published pro-
cedure22 and precipitated as sodium salt. 0.46 g  
(2 mmol) N-Ph-5-Cl-salimH in 30 mL ethanol absolute 
was added to the solution of 0.26 g (1 mmol)  
RuCl3 · 3H2O in absolute alcohol (10 mL). The mixture 
was refluxed for 3 hours at 65−70 °C and the volume 
was reduced in rotary evaporator to the half of the initial 
volume. The precipitation was performed by adding the 
water solution of 0.058 g NaCl (1 mmol) / 1 mL. The 
dark green solid was washed with diethyl ether and 
dried over P2O5. Yield: 55 %. 
Anal. Calc. for NaRuC26H18Cl4O2N2; (%):  
C, 49.30; H, 2.86; N, 4.42. Found (%): C, 48.36;  
H, 2.91; N, 4.21. MALDI-TOF MS m/z: 633.91 
([C26H18 Cl4O2N2Ru]−, 100 %). IR(KBr) νmax  / cm−1: 
1583 vs (C=N), 1352 m (C−O phen), 424 w (Ru−O),  
669 w (Ru-N). UV / Vis [CH2Cl2], λmax/nm: 340 and 
495 (ε / M−1 cm−1): 6600 and 4144. 
 
Sodium dichloro-bis[N-butylsalicylideniminatoN,O]-
ruthenate(III), Na[RuCl2(N-Bu-5-H-salim)2]. To the 
solution of RuCl3 · 3H2O (0.10 g, 0.38 mmol) in 5 mL 
absolute ethanol, 0.76 mmol freshly prepared  
butylsalicylidenimine was added. Reaction mixture  
was kept at 80 °C within 90 minutes in rotary  
evaporator whereby the resulting solution has changed 
the color from brown to dark green. Precipitation  
was performed with 1 mL water solution of NaCl  
(0.02 g, 0.38 mmol). The resulting solution was kept 
overnight in ice-salt bath afterward the dark solid was 
filtered off and washed with ice-cold diethyleter.  
Yield: 43 %. 
Anal. Calc. for NaC22H28Cl2O2N2Ru; 
Na+[RuCl2C22H28O2N2]−; (%): C, 48.30; H, 5.16;  
N, 5.12. Found (%): C, 48.06; H, 5.28; N, 4.81. 
MALDI-TOF MS m/z: 524.0604 ([RuCl2C22H28O2N2]−, 
100 %). IR(KBr) νmax / cm−1: 1606 vs (C=N), 1305 m 
(C−O phen), 404 w (Ru−O), 669 w (Ru−N). UV / Vis 
[CH2Cl2], λmax  / nm: 415, (ε / M−1 cm−1): 1408. 
 
 
Physical Measurements  
Elemental analyses were performed on a Perkin Elmer 
2400 Series CHNS/O Analyzer. Mass spectra were 
obtained on a matrix-assisted laser desorption / ioniza-
tion–time–of-flight MALDI-TOF/TOF mass spectrome-
ter (4800 Plus MALDI TOF/TOF analyzer, Applied 
Biosystems Inc., Foster City, CA, USA) equipped with 
Nd:YAG laser operating at 355 nm with firing rate  
200 Hz in the negative ion reflector mode. 1600 shots 
per spectrum was taken with mass range 10−1500 Da, 
focus mass 500 Da and delay time 100 ns. Small 
amount of sample (on pipette tip) was resuspended in  
10 µl of DHB MALDI matrix (5 mg/mL; dissolved in 
50/50 acetonitrile/water, v/v) and 1 µl was spotted on 
MALDI plate. The spectrum was internally calibrated 
providing measured mass accuracy within 5 ppm  
of theoretical mass riboflavin and 3-aminosalicylic  
acid were used as internal calibrants in negative ion 
mode. 
The infrared spectra were recorded as KBr pellets 
on a Perkin Elmer spectrum BX FTIR System in the 
region 4000−400 cm−1. UV/visible spectra, hydrolyses 
and CT DNA binding were measured on a Perkin Elmer 
lambda 35 spectrophotometer. Hydrolysis experiments 
were performed by adding the concentrated solution of 
complexes in DMSO to water buffered solutions (phos-
phate buffer, pH 7.5). The stock solution of CT DNA 
was prepared in Tris-HCl buffer at pH 7.4 and stored at 
4 °C maximally 1−4 days. The concentration of DNA 
was calculated on the basis of extinction coefficient 
6600 M−1 cm−1 at 260 nm.23 The purification of DNA by 
phenol extraction methods improved the ratio of UV 
absorbance at 260 and 280 nm A260/A280 ca. 1.8, indicat-
ing that DNA was satisfactory free from proteins. The 
absorption of DNA itself was removed by adding the 
same amount of DNA in reference solutions as in ruthe-
nium complex-DNA solutions. Concentrated stock solu-
tions of complexes were prepared by initial dissolving 
compounds in small amount of DMSO and diluting to 
the required concentrations. 
Cyclic voltammograms of Na[RuCl2(N-R-5-X-
salim)2] were recorded on an electrochemical work-
station Autolab potentiostat/galvanostat (PGSTAT 12) 
in DMF (N,N-dimethylformamide) solution with sodium 
perchlorate as supporting electrolyte using glassy car-
bon working electrode and Ag/AgCl reference electrode 
in the range of potential of −1.5 to +0.1 V, with scan 
rate rate 0.8 V s−1. Working electrode was polished prior 
to measurements with 1 μm diamond paste. Electro-
chemical titrations of ruthenium compounds with CT 
DNA were recorded by cyclic voltammetry in Tris–HCl 
buffered water solution (pH 7.4), at ambient tempera-
ture in 5 mL-volume conical compartment self-made  
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cell. The volume of the cell is adapted to the experi-
ments meaning to the required volumes of Na[RuCl2(N-
R-5-X-salim)2] solutions (2 mL) and added μL-amounts 
(0−60) of CT DNA. 
 
RESULTS AND DISCUSSION 
Synthesis and Spectroscopic Studies  
Synthesis 
Na[RuCl2(N-R-5-X-salim)2] compounds were synthe-
sized from RuCl3 and freshly prepared ligands, butylsa-
licylidenime (R = C4H9, X = H) and N-phenyl-5-chlo-
rosalicylidiemine (R= C6H5, H = Cl), in absolute ethanol 
solutions in molar ratio 1 : 2. The water suspended in 
liquid Schiff base was not removed before the use  
because the synthesis of final product was not affected 
by the presence of water; moreover it is known that, in 
some cases, the traces of water in butylsalicylidenimine 
assists replacement of leaving group by Schiff base in 
starting compound.24 The precipitations of anionic  
complexes were performed by water solution of sodium 
chloride. The dark green solids are quite stable in air, 
insoluble in water, soluble in acetonitrile, DMF,  
acetone, ethyl alcohol, DMSO, CH2Cl2. The molar ratio 
of ruthenium and Schiff bases had to provide coordina-
tion of two anionic O, N ligands, keeping in octahedral 
environment of ruthenium, two chlorides as easily leav-
ing groups. The characterization of compounds is based 
on elemental CHN analytical data, mass spectrum 
MALDI-TOF (Matrix Assisted Laser Desorption / Ioni-
zation; Time of flight mass analyzer), infrared and UV / 
visible spectroscopic measurements. Mass spectra 
showed molecular ions (M−) at m/z (100 %) = 524.06 
which corresponds to [C22H28Cl2O2N2Ru]− and m/z  
(100 %) found for [C26H18Cl4O2N2Ru] 633.91.  
Infrared Spectroscopy 
Infrared spectra of titled compounds and free ligands 
clearly demonstrate the mode of binding via azomethine 
nitrogen and deprotonated phenolic oxygen to  
ruthenium strongly supporting the octahedral structure 
of the compounds. Strong absorptions at 1583  
and 1606 cm−1 in Na[RuCl2(N-Ph-5-Cl-salim)2] and 
Na[RuCl2(N-Bu-salim)2] are assigned to the stretching 
frequency of –CH=N−, compared to the frequencies at 
1615 and 1633 cm−1 in free ligands, respectively. The 
shift of the frequencies after coordination toward lower 
wavenumbers for 32 and 27 cm−1 is a proof of strongly 
bound azomethine nitrogen on ruthenium. Taking into 
account the shifts as the rough measure of weakening  
of C=N from azomethine the absorptions at 669 cm−1 
were assigned to Ru−N in both compounds. On  
contrary, phenolic C−O bond shows shift from 1271  
and 1280 cm−1 in corresponding free ligands to 1305 
and 1352 cm−1 in Na[RuCl2(N-Ph-5-Cl-salim)2] and 
Na[RuCl2(N-Bu-salim)2] as a result of increased  
electronic density on C−O(Ru) after deprotonization of 
C−O(H). The absorptions in the region 2850−2900 cm−1 
were assigned to CH vibrations while moderate  
absorption at 1518 cm−1 belongs to skeletal C=C vibra-
tions. The weak absorptions, appeared around 425 cm−1 




Electronic spectra of free Schiff bases and correspond-
ing complexes were recorded in CH2Cl2 solutions. 
Na[RuCl2(N-Bu-5-H-salim)2] exhibits one broad ab-
sorption band centered about 415 nm arising from 
intraligand transition of whole molecule of Schiff base. 
Compared to free ligand , when Ru−N bond is formed, 
the lone pair on nitrogen atom becomes stabilized and 
absorption assigned to n → π* showed hypsohromic 
shift (blue shift) for 7 nm. In Na[RuCl2(N-Ph-5-Cl-
salim)2] this absorption appears around 495 nm.  
Weakly defined broad absorption centered around  
350 nm, assigned to the transition of –HC=N- group, is 
superimposed by Cl → Ru(III) LMCT transition in 
Na[RuCl2(N-Bu-5-H-salim)2] while in phenyl derivative 
a well defined band appears around 338 nm. Weak 
broad absorption for both compounds, centered on  
600 nm in the region of d-d spin allowed transition of 
low spin t2g5 Ru(III), can be assigned to (2T2g → 
2A2g).25,26 
Figure 1. Scheme of preparation of Na[RuCl2(N-R-5-X-
salim)2]; R = C4H9 (Bu); C6H5 (Ph); X = H, Cl. 
 
Figure 2. Hydrolysis of Na[RuCl2(N-Bu-salim)2] in phosphate
buffer (pH 7.50; 0.1 M NaCl); c = 5.5 × 10−4 M; t = 120 min. 
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Behavior in Solutions 
Understanding of behavior of compounds in solution, 
e.g. hydrolysis and electron transfer processes are 
thought to be very important for potential biological 
activity and possible antitumor purpose of complex 
compounds. The hydrolyses of Na[RuCl2(N-R-5-X-
salim)2] compounds under physiological condition in 
phosphate buffer (pH 7.5; 0.1 M NaCl) designates  
reasonable stabilization of ruthenium(III) after chelation 
and blue shift of the LMCT bands over the time. 
 
Cyclic Voltammetry Measurements 
Ru(III)/Ru(II) reduction potentials change with ligand 
environment and is thought to be very important for 
possible antitumor properties of a compound. The elec-
tronic effect of nitrogen from azomethine group and 
phenolate oxygen on reduction potential is different. 
More electronegative and smaller oxygen atom, hard in 
character stabilizes Ru(III), while nitrogen, as softer, 
prefers lower oxidation state. Kinetically, Ru(II) com-
pounds are more labile than Ru(III) which are believed 
to can be activated by reduction in vivo. Few  
compounds like gluthation in cells and ascorbic acid in 
blood are thought to contribute to the reduction in vivo. 
Cyclic voltammograms of Na[RuCl2(N-Bu-salim)2] and 
Na[RuCl2(N-Ph-5-Cl-salim)2] in DMF solution with 
sodium perchlorate as supporting electrolyte show  
defined Epa anodic peaks at −0.277 and −0.309 V  
respectively, while Epc cathodic peaks change slightly 
from −0.901 to −0.905 V. The half-wave potentials, 
assigned to Ru(III)/Ru(II) couple, (E1/2) = −0.607 V for 
Na[RuCl2(N-Bu-salim)2] and (E1/2) = −0.588 V for 
Na[RuCl2(N-Ph-5-Cl-salim)2], in addition to peak-to-
peak separation values and apparent reduction waves as 
result of stabilization of Ru(III) after coordination 
trough phenolic oxygen from salycilidenimine,27,28  
suggest the quasi-reversible one-electron transfer  
processes (Figure 4, Table 1). 
 
CT DNA Binding 
Spectroscopic Study 
Interaction of metal complex compounds with DNA is 
taken as important initial signal about possible evalua-
tion of biological properties of a compound. Activity of 
ruthenium compounds toward DNA, as a key target for 
anticancer drugs, may originate from either their cova-
lent interaction with DNA nucleobases or non-covalent 
binding such as electrostatic interaction of positively 
charged species with phosphate backbone and intercala-
tion as well. Electronic absorption is very useful method 
to determine the binding properties of metal complexes 
Table 1. Characteristic potentials of Na[RuCl2(N-Ph-5-Cl-salim)2] and Na[RuCl2(N-Bu-salim)2] from cyclic voltammetry meas-
urements in DMF solution with NaClO4 supporting electrolyte 
Complex Epc / V Epa / V E1/2 / V ΔE / V 
Na[RuCl2(N-Ph-5-Cl-salim)2] −0.905 −0.309 −0.607 0.596 
Na[RuCl2(N-Bu-salim)2] −0.901 −0.277 −0.589 0.624 
 
Figure 3. Hydrolysis of Na[RuCl2(N-Ph-5-Cl-salim)2] in
phosphate buffer (pH 7.50; 0.1 M NaCl); c = 1.22 × 10−4 M;
 t = 90 min. Figure 4. Cyclic voltammograms of Na[RuCl2(N-Bu-salim)2] 
and Na[RuCl2(N-Ph-5-Cl-salim)2]; DMF solution, supporting 
electrolyte NaClO4; working electrode-glassy carbon vs
Ag/AgCl reference electrode; scan rate 0.8 V s−1; E = 0.5 (Epa
+ Epc); ∆Ep = Epa − Epc. 
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with DNA. Spectroscopic study of interaction of 
Na[RuCl2(N-Ph-5-Cl-salim)2] and Na[RuCl2(N-Bu-
salim)2] with CT DNA has performed by titration of 
fixed concentration of complex compounds with  
increasing concentrations of calf thymus DNA (CT 
DNA) in the [DNA] / [complex] ratio range 0−2.88 and 
0−3.51, respectively. The constants of binding, Kb were 
calculated on the basis of equation (1):29 
 
  (1) 
εa, εf and εb represent apparent extinction coefficients for 
particular measurements (Aobs / [DNA]), free complex 
and completely bound form, respectively. By plotting 
[DNA] / (εa − εf) vs [DNA], Kb is obtained as the ratio of 
the slope and intercept. Experimental data of spectro-
scopic measurements for interaction metal compounds-
DNA are given in Figures 5 and 6. 
Weak bathochromic shifts, hypochromism and 
constant binding values of order 104 M−1 indicate that 
both compounds, containing Schiff bases derived from 
salicylaldehyde, act as moderate DNA-intercalators.30 
 
Electrochemical Study 
Electrochemical method is useful complement method 
for UV / visible spectroscopic investigation of metal 
complex intercalative mode binding to DNA. Here we 
describe electrochemical measurements of redox  
couples RuIIIcomplex / RuIIcomplex in the presence of incre-
asing amounts of CT DNA (Figures 7 and 8, Tables 2  
and 3). 
Shifts of E1/2 for both compounds toward more 
positive values, with increasing concentration of added 
DNA, suggest different ability of Ru(II) and Ru(III) 
compounds to bind DNA as a result of intercalation 
mode of binding. Changes in peak-to-peak separation, 
after addition of DNA, indicate an increase in reversibil-
ity of one-electron redox processes. 
 
Figure 5. Graphical calculation of Kb (4.32 × 104 M−1) on the basis of spectrophotometric titration of Na[RuCl2(N-Ph-5-Cl-
salim)2] by CT DNA. Insets: upper left- experimental data for Kb calculation; bottom right-absorption spectra of 8.03 × 10−5 M
Na[RuCl2(N-Ph-5-Cl-salim)2] with increasing concentration of CT DNA (stock solution c = 7.98 × 10−3 M). 
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Figure 6. Graphical calculation of Kb (1.81 × 104 M−1) on the basis of spectrophotometric titration of Na[RuCl2(N-Bu-salim)2] by
CT DNA. Insets: upper left- absorption spectra of 9.80 × 10−5 M Na[RuCl2(N-Bu-salim)2] with increasing concentration of CT
DNA (stock solution c = 9.75 × 10−3); bottom right-experimental data for Kb calculation.
 
Figure 8. Cyclic voltammograms of 4.9 × 10−5 M
Na[RuCl2(N-Bu-salim)2] in 1) absence; 2) presence of 9.8 ×
10−5 M DNA ([DNA] / [complex] = 2); 3) presence of 5.88 ×
10−4 M DNA ([DNA] / [complex] = 12); pH 7.4, Tris-HCl
buffer. Working electrode-glassy carbon vs Ag/AgCl reference
electrode; scan rate 0.8 V s−1; E1/2 = 0.5 (Epa + Epc);
∆Ep = Epa − Epc. 
 
Figure 7. Cyclic voltammograms of 5 × 10−5 M
Na[RuCl2(N-Ph-5-Cl-salim)2] in 1) absence DNA; 2) presence
of 9.8 × 10−5 M DNA ([DNA] / [complex] = 2); 3) presence of
5.88 × 10−4 M DNA. ([DNA] / [complex] = 12); pH 7.4, Tris-
HCl buffer. Working electrode-glassy carbon vs Ag/AgCl
reference electrode; scan rate 0.8 V s−1; E1/2 = 0.5 (Epa + Epc);
∆Ep = Epa − Epc. 
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CONCLUSION 
Some ruthenium complexes with planar and fused aro-
matic π-electronic acceptor system or similar aromatic 
heterocyclic rings are described as DNA intercalators 
which are able to keep base pair separated distorting 
double helix structure of DNA.31,32 Less extended planar 
ligands may cause partial intercalation due to omitting 
of the ancillary ligands and phosphate backbone e.g. in 
the cases of some 1,10-phenanthroline compounds.33,34 
Although two easily leaving chlorides in the structures 
of Na[RuCl2(N-R-5-X-salim)2] do not exclude a priori 
covalent binding or even electrostatic interaction of 
neutral and positively charged complex species  
produced by loss of chlorides, our spectroscopic and 
electrochemical investigations suggest an intercalative 
mode of binding with constant of order 104 M−1. Possi-
bly, this is the first report on anionic Ru(III) compounds 
with Schiff bases derived from salicyladehyde and  
simple amines which act as DNA intercalators. 
We showed here that ruthenium(III) complexes 
containing unlike, non-fused kinds of aromatic ligands, 
such as N-phenyl-5-chlorosalicylidenimine and  
N-butylsalicylidenimine cause intercalation of CT DNA. 
In the case of Na[RuCl2(N-Ph-5-Cl-salim)2], with  
π-system aromatic ring-azomethine-aromatic ring (two 
aromates bridged by azometine), Kb = 4.32 × 104 M−1 
value indicates good intercalating properties. The varia-
tion in structure of Schiff base ligands by altering one 
aromatic ring with butyl (aromatic – azomethine − bu-
tyl) in Na[RuCl2(N-Bu-salim)2] do not affect Kb value  
significantly (Kb = 1.81 × 104 M−1). This implies that 
aromatic − azomethine part of Schiff base acts as an 
intercalating chromophore for DNA bases. 
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